Search Results for: charles serhan

In the first part of an interview series, Charles Serhan, PhD, DSc answers the question “How and when did you determine the significant of resolution physiology to human health?” Dr. Serhan shares an edifying history of resolution physiology: from early microscope observations of leukocytic infiltration, to the turning point lipoxin discoveries in the 1990s, to the latest research insights and inquiries today. Once thought to be a passive event mediated by chemokines, resolution is now known to be an active…

In this interview, Professor Charles Serhan, PhD, DSc describes new work highlighting the connection between specialized pro-resolving mediators (SPMs) and the vagus nerve. Dr. Serhan reflects back at his proudest moments of his career, and on the most exciting recent developments. Finally, Dr. Serhan delivers a message on the state of resolution science today, and what is needed to advance SPM-based therapies in the future. Charles Serhan, PhD, DSc is Director of the Center for Experimental Therapeutics and Reperfusion Injury…

As the current pandemic rages on, several hundred clinical trials are recruiting and ongoing hoping to identify efficacious antiviral and anti-inflammatory strategies. In a new commentary published in the journal Cancer Metastasis and Reviews (Springer Nature publishing group),1 a group of prominent researchers proposed a promising, complementary direction worthy of consideration: targeting inflammation resolution. Who contributed to this commentary? The article was led by Dipak Panigrahy, MD, at Beth Israel Deaconess Medical Center of Harvard Medical School, who has had…

by Bianca Garilli, ND, IFMCP Too much inflammation can be a bad thing When the topic of chronic disease comes up, the term inflammation is sure to be close behind. In fact, inflammation has received a fairly bad rap in the past years as research has underscored its prominent role in the promotion and perpetuation of many aspects of physiological dysfunction. Although not the root cause per se, inflammation has been shown to “add fuel to the fire” of a…

In this Grand Rounds presentation, Niccolò Terrando, PhD shares scientific research on the role of specialized pro-resolving mediators (SPMs) in perioperative neurocognitive disorders. Dr. Terrando uses a preclinical mouse model to study postoperative neuroinflammation and elucidate the impact of SPMs in neuroglia activity and modulating memory. Perioperative neurocognitive disorders (PND) encompass complications like postoperative delirium and longer-lasting postoperative cognitive dysfunction, which often negatively impact recovery in older adults. These complications can lead to significant, long-term morbidity for the patient and…

15. Insights from the Metagenics Lifestyle Summit 2015 in Phoenix, AZ: Charles Serhan, PhD In this short video, Dr. Charles Serhan discusses the differences between specialized pro-resolving mediators (SPMs) formulations for clinical application. He indicates that different product formulations must be assessed for efficacy for specific uses. Further, SPMs themselves are natural molecules and are not all created equally. They are tissue-specific, so some promote tissue regeneration while others are more effective at phagocytosis, for example.

12. Insights from the Metagenics Lifestyle Summit 2015 in Phoenix, AZ: Charles Serhan, PhD Specialized pro-resolving mediators (SPMs) offer an exciting opportunity to treat and manage the inflammation often associated with chronic disease. The precursors to SPMs are omega-3 essential fatty acids, EPA and DHA. In this short video with Dr. Charles Serhan of Harvard Medical School, Metagenics Institute inquires about whether it is possible for humans to consume too much EPA and DHA. Dr. Serhan responds that it may…

In the 2nd part of a new SPM interview series, Charles Serhan, PhD, DSc answers the question: “Can you describe some therapeutic areas where specialized pro-resolving mediators are currently being investigated for clinical use?” Dr. Serhan discusses the most current therapeutic research assessing SPM efficacy, including pulmonary, cardiometabolic, vascular, joint and cognitive health, as well as pain and wound healing. Charles Serhan, PhD, DSc is Director of the Center for Experimental Therapeutics and Reperfusion Injury at Brigham and Women’s Hospital…

In the 3rd part of a new SPM interview series, Charles Serhan, PhD, DSc answers the question: “Are there any recent findings or results in resolvins research that have surprised you?” Dr. Serhan discusses the recently discovered resolution role of specialized pro-resolving mediators (SPMs) in the adaptive immune response, including the regulation of B cell function and facilitating antibody production. Charles Serhan, PhD, DSc is Director of the Center for Experimental Therapeutics and Reperfusion Injury at Brigham and Women’s Hospital…

In the 4th part of the SPM interview series with Charles Serhan, PhD, DSc, he answers the question: “Besides peripheral blood, can pro-resolving mediators be measured in other tissues? If so, which ones?” Dr. Serhan shares current research findings on SPM measurement in the human body, demonstrating several human tissues and fluids where SPMs have been found. These discoveries will directly inform analytical methods for SPM measurement moving forward. Dr. Serhan also discusses the “coagulation clock”, as well as gender-…